AAAAAA
Results:
1-8
|
Results: 8
Authors:
Holmes, MB
Kabbani, SS
Terrien, CM
Watkins, MW
Sobel, BE
Schneider, DJ
Citation: Mb. Holmes et al., Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab, CORON ART D, 12(3), 2001, pp. 245-253
Authors:
Schneider, DJ
Baumann, PQ
Holmes, MB
Taatjes, DJ
Sobel, BE
Citation: Dj. Schneider et al., Time and dose dependent augmentation of inhibitory effects of abciximab byaspirin, THROMB HAEM, 85(2), 2001, pp. 309-313
Authors:
Holmes, MB
Schneider, DJ
Hayes, MG
Sobel, BE
Mann, KG
Citation: Mb. Holmes et al., Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy, CIRCULATION, 102(17), 2000, pp. 2051-2057
Authors:
Holmes, MB
Kabbani, S
Watkins, MW
Battle, RW
Schneider, DJ
Citation: Mb. Holmes et al., Abciximab-associated pseudothrombocytopenia, CIRCULATION, 101(8), 2000, pp. 938-939
Authors:
Holmes, MB
Sobel, BE
Cannon, CP
Schneider, DJ
Citation: Mb. Holmes et al., Increased platelet reactivity in patients given Orbofiban after an acute coronary syndrome: An OPUS-TIMI 16 substudy, AM J CARD, 85(4), 2000, pp. 491-493
Authors:
Holmes, MB
Schneider, DJ
Citation: Mb. Holmes et Dj. Schneider, Optimizing antiplatelet therapy in patients with acute coronary syndromes:A role for monitoring platelet reactivity, J INVAS CAR, 11, 1999, pp. 21C-25C
Authors:
Holmes, MB
Sobel, BE
Howard, DB
Schneider, DJ
Citation: Mb. Holmes et al., Differences between activation thresholds for platelet P-selectin and glycoprotein IIb-IIIa expression and their clinical implications, THROMB RES, 95(2), 1999, pp. 75-82
Authors:
Holmes, MB
Sobel, BE
Schneider, DJ
Citation: Mb. Holmes et al., Variable responses to inhibition of fibrinogen binding induced by Tirofiban and Eptifibatide in blood from healthy subjects, AM J CARD, 84(2), 1999, pp. 203-207
Risultati:
1-8
|